Brief: MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy
05/08/2025 14:16
Aug 5 (Reuters) - MEI Pharma Inc MEIP.O: MEI PHARMA ACQUIRES LITECOIN, LAUNCHES $100M INSTITUTIONAL TREASURY STRATEGY WITH CHARLIE LEE AND GSR ADVISING MEI PHARMA INC - BUYS 929,548 LITECOIN TOKENS VALUED AT $110.4 MILLION MEI PHARMA INC - CONTINUES PRE-CLINICAL ACTIVITIES WITH DRUG CANDIDATE VORUCICLIB Source text: ID:nBw26QNKWa Further company coverage: MEIP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations